Synthesis and biological evaluation of novel 1,2,3-triazole hybrids of cabotegravir: identification of potent antitumor activity against lung cancer
In pursuit of discovering novel anticancer agents, we designed and synthesized a series of novel 1,2,3-triazole hybrids based on cabotegravir analogues. These compounds were subjected to initial biological evaluations to assess their anticancer activities against non-small-cell lung cancer (NSCLC)....
Saved in:
Main Authors: | Yajie Guo (Author), Dan Sang (Author), Bin Guo (Author), Dan Wang (Author), Xinyue Xu (Author), Huili Wang (Author), Cuilan Hou (Author), Longfei Mao (Author), Fang Li (Author), Sanqiang Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity
by: Huaxia Xie, et al.
Published: (2023) -
Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
by: Peng Deng, et al.
Published: (2022) -
Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors
by: Xixi Hou, et al.
Published: (2022) -
Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
by: Long-fei Mao, et al.
Published: (2020) -
Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
by: Jiahui Ye, et al.
Published: (2021)